🇺🇸 FDA
Patent

US 8501678

Variant activin receptor polypeptides and uses thereof

granted A61KA61K31/513A61K31/655

Quick answer

US patent 8501678 (Variant activin receptor polypeptides and uses thereof) held by Atara Biotherapeutics, Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Atara Biotherapeutics, Inc.
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/513, A61K31/655, A61K31/704, A61K38/177